tiprankstipranks
Trending News
More News >

BeOne Medicines Ltd. Announces Share Options and RSUs Grant

Story Highlights
BeOne Medicines Ltd. Announces Share Options and RSUs Grant

Confident Investing Starts Here:

BeiGene Ltd ( (HK:6160) ) has issued an announcement.

BeOne Medicines Ltd., a Switzerland-based corporation, announced the grant of share options and restricted share units under its 2016 Share Option and Incentive Plan. The compensation committee granted options to subscribe for 21,140 American Depositary Shares (ADSs) to two grantees and restricted share units involving 54,538 ADSs to 368 grantees. This move is part of the company’s strategy to incentivize and retain talent, potentially impacting its operational efficiency and market competitiveness.

The most recent analyst rating on (HK:6160) stock is a Buy with a HK$206.60 price target. To see the full list of analyst forecasts on BeiGene Ltd stock, see the HK:6160 Stock Forecast page.

More about BeiGene Ltd

Average Trading Volume: 6,511,791

Technical Sentiment Signal: Buy

Current Market Cap: HK$238.4B

See more insights into 6160 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App